WeVote
Log In

Bill

Bill

AB 76

Revises provisions relating to cannabis. (BDR 56-286)

2025 Regular Session

Streamlines Cannabis Compliance Board operations and tightens licensing, labeling, packaging, inventory, and enforcement to curb unlicensed activity and protect consumers.

Chapter 459.
0
WeVote Research Nonpartisan
Bill Summary · AB 76

AB 76 (BDR 56-286) — Summary (Cannabis Regulatory Revisions)

Status (per provided record)
- Sponsor: Assembly Committee on Judiciary (on behalf of the Cannabis Compliance Board)
- Enrolled and presented to Governor: 2025-06-06 / 2025-06-10
- Chaptered: Chapter 459 (2025-06-11)
- Fiscal note: Effect on State: Yes. Effect on Local Government: No.
- Note: the legislative history also records a gubernatorial veto action dated 2025-10-13; readers should verify current status with official state records.

Purpose and intent
AB 76 is an agency‑generated omnibus bill to (1) streamline and clarify the Cannabis Compliance Board’s (CCB) administrative and enforcement processes, (2) revise licensing, labeling, packaging and inventory requirements for cannabis establishments, (3) enhance tools to investigate and address unlicensed activity, (4) strengthen consumer protection and public‑health response authority, and (5) standardize certain definitions and confidentiality rules (including tribal information).

Key provisions and substantive changes
- Administrative discipline and hearings
- Establishes hearing officers to conduct disciplinary hearings and issue decisions; Board review is permitted; judicial review remains available.
- Revises roles in investigations and complaints (Executive Director authorized to transmit suspected violations for investigation; amendments preserved Board authority to issue formal complaints).
- Authorizes non‑punitive tools: letters of warning, letters of concern, non‑punitive admonishments.

  • Investigations and enforcement

    • Explicit statutory authority for the CCB to issue summonses and subpoenas and to pursue participants in unlicensed cannabis activity.
    • Creates expedited authority for CCB agents to order immediate suspension/closure of a cannabis establishment when conditions constitute a “substantial hazard to the public health,” with shortened reinspection and hearing timelines (reinspection as soon as practicable, within 2 business days; hearing within 14 days).

  • Packaging, labeling, advertising, and definitions

    • Adds statutory definitions for “label” and “packaging.”
    • Prohibits duplicative labeling demands (e.g., wholesale packages need only seed‑to‑sale tags necessary for tracking).
    • Restricts certain imagery (amendments prohibit “anthropomorphic” images on packaging) while allowing fruit images; adjusts advertising/packaging rules to reflect amendments.
    • Revises single‑package limits (increases for some concentrated products and topicals) and retention requirements for certain medical records (extended retention narrowly applied to out‑of‑state medical card holders).

  • Product and testing rules

    • Refines the definition of “synthetic cannabinoid” to cover cannabinoids produced artificially or not derived directly without chemical reagents from Cannabis, with specific exclusions for certain THC produced by defined processes.
    • Expands and updates inventory control and reporting requirements (applies certain medical tracking rules to adult‑use and dual licensees).
    • Revises independent testing laboratory requirements (detail in bill).

  • Tribal and confidentiality provisions

    • Clarifies that information received from tribal governments under agreements remains the property of the tribe, is not a public record, and must be kept confidential.

  • Studies and fiscal matters (added by amendment)

    • Requires the Cannabis Advisory Commission to form subcommittees and study: (a) regulation, distribution and taxation of hemp‑derived intoxicating THC products (report due to lawmakers by 11/09/2026), and (b) potential changes to cannabis tax structure (e.g., wholesale excise elimination coupled with retail rate adjustments).

Who is affected
- Cannabis Compliance Board (administration and enforcement procedures)
- Licensed cannabis establishments, license applicants, and licensees (operation, packaging, labeling, inventory, disciplinary exposure)
- Independent testing laboratories
- Entities and individuals involved in unlicensed cannabis activity (greater subpoena/enforcement exposure)
- Tribal governments (data ownership and confidentiality)
- Consumers and public‑health stakeholders (changes to product limits, packaging, and public‑health enforcement)

Procedural/timeline notes
- The bill underwent multiple amendments in committee and on the floor (notably Amendments 173 and 799), reflecting CCB and stakeholder input (e.g., removal of some proposed provisions such as vending machine sales in later amendments).
- Several timing changes were made by amendment to accelerate administrative reinspection and hearing timelines for substantial hazards.
- Check the official Nevada Legislative Counsel Bureau or Secretary of State for the final enacted status given the mixed entries in the provided history (chaptered as Chapter 459 on 6/11/2025; a veto action is also recorded 10/13/2025).

For more detail
- The bill is comprehensive and technical; interested readers (licensees, local regulators, public‑health officials, tribal authorities) should consult the enrolled/annotated bill text and committee analyses for section‑by‑section language and regulatory consequences.

Compiled from official sources — confirm details with the bill’s official record.

Sign in to ask a question.